Search

everythinglearnresearchcommunity

for

Search:↓

Treating hair loss effectively may require a multi-sided approach, using different treatments together, and topical treatments could be more effective and safer than oral ones.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Men with early balding showed higher levels of certain genes linked to hair loss and possibly prostate cancer.

Some people experience lasting sexual, psychological, and sleep problems after using finasteride or SSRI antidepressants, possibly due to similar underlying causes.

Low-dose DMSO may help treat castration-resistant prostate cancer by reducing key cancer cell receptors.

Hormonal interactions, especially involving DHT and estrogen, play a key role in BPH development and treatment.

A new compound slows cancer cell growth and causes cell death by blocking cell cycle progression and increasing cell-damaging molecules.

Standardized guidelines are needed to improve drug-loaded extracellular vesicle purification.

OnabotulinumtoxinA is used to treat wrinkles, pain, sweating, hair loss, and more by temporarily paralyzing muscles and affecting pain pathways.

MX1 and AR genes are linked to milder COVID-19, while TMPRSS2 increases severe risk, especially in women.

Synthetic curcumin derivatives improve treatment for diabetes and cancer.

Emblica officinalis and Eclipta alba may help treat hair loss naturally.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

Prostate cancer prevention now focuses on healthy diets and some medications, not vitamins.

High TNF-α levels may increase hair loss risk after PRP therapy.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

5αR inhibitors help slow early prostate cancer cell growth, suggesting combined treatments are needed.

Short-term finasteride treatment may lower some cell death factors in prostate cancer cells.

Finasteride and dutasteride reduce neurosteroid production, possibly helping treat glioblastoma.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

Male pattern hair loss could hint at androgens affecting COVID-19 severity.

The conclusion is to use scalp cooling, gentle hair care, and treatments like minoxidil for managing hair loss from chemotherapy, and stresses the need for more research and collaboration in this area.

Some plant-derived compounds may help with hormonal conditions, but more research is needed to confirm their effectiveness.

DHT affects hair follicle cells by changing microRNA levels, leading to less cell growth and more cell death.

Dutasteride reduces DHT more effectively than finasteride.

Low dose finasteride causes only minor changes in PSA levels in men over 50 with BPH.

Low dose finasteride causes only small changes in PSA levels in older men with BPH.

Shorter PSADT after prostate surgery is linked to higher risk of death.

A new method helps detect androgen receptor movement in cells, aiding research on hair loss treatments.